Genome-wide differential expression profiling of long non-coding RNAs in FOXA2 knockout iPSC-derived pancreatic cells

Ahmed K Elsayed1,2,3, Nehad M Alajez3,4, Essam M Abdelalim5,6

  • 1Diabetes Research Center (DRC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), PO Box 34110, Doha, Qatar.

Abstract

Insights

Loss of FOXA2 impacts human pancreas development by altering long non-coding RNA (lncRNA) profiles. This study reveals lncRNA-mRNA networks crucial for pancreatic islet formation, offering new therapeutic targets.

Area of Science:

  • Stem cell biology
  • Developmental biology
  • Genomics

Background:

  • Forkhead box A2 (FOXA2) is vital for human pancreas development.
  • Reduced FOXA2 in induced pluripotent stem cells (iPSCs) impairs pancreatic islet cell mass.
  • The role of long non-coding RNAs (lncRNAs) in FOXA2-mediated pancreatic development is unclear.

Discussion:

  • FOXA2 deficiency in iPSCs alters lncRNA expression during pancreatic progenitor and islet differentiation.
  • Co-expression networks reveal links between downregulated lncRNAs and dysregulated pancreatic mRNAs.
  • Specific lncRNA-mRNA interactions are conserved across pancreatic differentiation stages.

Key Insights:

  • Significant changes in lncRNA profiles (downregulation and upregulation) occur in FOXA2-deficient pancreatic progenitors and islet cells.
  • A strong correlation exists between lncRNAs and key pancreatic genes/transcription factors.
  • Twelve differentially expressed lncRNAs (DE-lncRNAs) strongly correlate with downregulated pancreatic genes in both stages.

Outlook:

  • FOXA2-dependent pancreatic islet development defects are linked to lncRNA expression alterations.
  • lncRNA-mRNA networks play a critical role in regulating pancreatic islet development.
  • Further research into these networks may uncover novel therapeutic strategies for pancreatic diseases.

Related Concept Videos